Correlation Between Axsome Therapeutics and INmune Bio
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and INmune Bio, you can compare the effects of market volatilities on Axsome Therapeutics and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and INmune Bio.
Diversification Opportunities for Axsome Therapeutics and INmune Bio
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Axsome and INmune is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and INmune Bio go up and down completely randomly.
Pair Corralation between Axsome Therapeutics and INmune Bio
Given the investment horizon of 90 days Axsome Therapeutics is expected to generate 0.58 times more return on investment than INmune Bio. However, Axsome Therapeutics is 1.73 times less risky than INmune Bio. It trades about 0.03 of its potential returns per unit of risk. INmune Bio is currently generating about 0.01 per unit of risk. If you would invest 7,729 in Axsome Therapeutics on August 26, 2024 and sell it today you would earn a total of 2,139 from holding Axsome Therapeutics or generate 27.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Axsome Therapeutics vs. INmune Bio
Performance |
| Timeline |
| Axsome Therapeutics |
| INmune Bio |
Axsome Therapeutics and INmune Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Axsome Therapeutics and INmune Bio
The main advantage of trading using opposite Axsome Therapeutics and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.| Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
| INmune Bio vs. Tff Pharmaceuticals | INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |